Drug profile · INN
bromocriptine
PARLODEL
bromocriptine (PARLODEL) is a d2-like dopamine receptor agonist. Associated with Sandoz Pty Ltd.
TGA: approved
Patents linked 0
Pipeline programs 1
News articles 0
Drug details — bromocriptine
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 1
- Data quality
- 0.81
Quick answer
bromocriptine (PARLODEL) is a d2-like dopamine receptor agonist. Associated with Sandoz Pty Ltd.
Key facts
INN bromocriptine
Brand PARLODEL
Mechanism D2-like dopamine receptor agonist
Originator Sandoz Pty Ltd
Mechanism of action
D2-like dopamine receptor agonist
Approval history
| Authority | Status | Date |
|---|---|---|
| TGA | approved | — |
Pipeline programs
Frequently asked questions
What is bromocriptine?
bromocriptine (PARLODEL) is a d2-like dopamine receptor agonist. Associated with Sandoz Pty Ltd.
What is the brand name for bromocriptine?
PARLODEL is a marketed brand name for bromocriptine. Check FDA Drugs@FDA for the current US label holder and prescribing information.